Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review

Schizophrenia is among the fifteen most disabling diseases worldwide. Negative symptoms (NS) are highly prevalent in schizophrenia, negatively affect the functional outcome of the disorder, and their treatment is difficult and rarely specifically investigated. Serotonin-dopamine activity modulators...

Descripción completa

Detalles Bibliográficos
Autores principales: Brasso, Claudio, Colli, Gianluca, Sgro, Rodolfo, Bellino, Silvio, Bozzatello, Paola, Montemagni, Cristiana, Villari, Vincenzo, Rocca, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046337/
https://www.ncbi.nlm.nih.gov/pubmed/36979900
http://dx.doi.org/10.3390/biomedicines11030921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046337/
https://www.ncbi.nlm.nih.gov/pubmed/36979900
http://dx.doi.org/10.3390/biomedicines11030921

Ejemplares similares